Anaconda BioMed S.L. (www.anaconda.bio), headquartered in Barcelona, Spain, is among the world's innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN®, a novel 3rd Generation Stented Advanced Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS). Every 2 seconds someone in the world is undergoing a stroke. Every 10 seconds someone in the world dies from a stroke. In the USA, there are about 690,000 annual incidences of AIS.